Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Long-Term Investments (2021 - 2023)

Bioregenx (BRGX) has 3 years of Long-Term Investments data on record, last reported at $100.0 in Q4 2023.

  • For Q4 2023, Long-Term Investments fell 99.52% year-over-year to $100.0; the TTM value through Dec 2023 reached $100.0, down 99.52%, while the annual FY2023 figure was $100.0, 99.52% down from the prior year.
  • Long-Term Investments reached $100.0 in Q4 2023 per BRGX's latest filing, down from $200.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $60000.0 in Q4 2021 and bottomed at $100.0 in Q4 2023.
  • Average Long-Term Investments over 3 years is $29050.0, with a median of $31500.0 recorded in 2022.
  • Peak YoY movement for Long-Term Investments: crashed 65.0% in 2022, then crashed 99.52% in 2023.
  • A 3-year view of Long-Term Investments shows it stood at $60000.0 in 2021, then plummeted by 65.0% to $21000.0 in 2022, then plummeted by 99.52% to $100.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $100.0 in Q4 2023, $200.0 in Q3 2023, and $51000.0 in Q2 2023.